Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 974.05 6.05 (0.63%) Market Cap: 107.33 Bil Enterprise Value: 98.76 Bil PE Ratio: 28.78 PB Ratio: 3.98 GF Score: 94/100

Regeneron Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 08, 2022 / 06:30PM GMT
Release Date Price: $614.74 (-0.62%)
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst

Great. Good afternoon, everyone. Welcome, again, to Cowen's 42nd Annual Healthcare Conference. Thank you very much for joining us. My name is Tyler Van Buren. I'm a senior biotech analyst at Cowen. For our next session, we have a fireside chat with Regeneron. And it is my pleasure to introduce Bob Landry, the Chief Financial Officer and Executive Vice President of Finance and Neil Stahl, the Executive Vice President of R&D.

Bob and Neil, it's a pleasure to have you. Thank you very much for being here.

Robert E. Landry
Regeneron Pharmaceuticals, Inc. - Executive VP of Finance & CFO

Tyler, thanks for the invite. Always happy to be invited to the Cowen conference. Let me begin with our forward-looking statement. I'll get into some kind of opening remarks, and then we'll jump right into questions for Neil and myself.

So again, to remind the audience remarks made today include forward-looking statements about Regeneron. Each forward-looking statement is subject

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot